Literature DB >> 29624947

The Need for Societal Investment to Improve Cervical Cancer Outcomes in Nigeria: A commentary.

Jonah Musa1,2.   

Abstract

Although cervical cancer is a preventable cancer with a well-known natural history, it remains a huge burden in developing countries of sub-Saharan Africa where organized cervical cancer screening services are lacking. Developed countries that have invested on providing organized screening programs have made substantial progress in reducing both incidence and mortality due to cervical cancer. Implementing evidence-based interventions such as human papillomavirus (HPV) vaccination of young girls, early detection and treatment of premalignant conditions of the cervix through conventional Pap cytology, HPV screening or visual aided inspection with acetic acid could significantly reduce incidence of new cases at population level. Societal investment for such preventive services and provision of effective treatment for those diagnosed at early stages will yield economic benefits in reducing premature deaths of women at the prime of their productive lives. From a societal perspective, this should be a priority area for national investment towards the achievement of sustainable development in Nigeria and similar settings in Africa.

Entities:  

Keywords:  Cancer prevention; cervical cancer; society; treatment

Mesh:

Year:  2017        PMID: 29624947      PMCID: PMC7039416          DOI: 10.29063/ajrh2017/v21i4.2

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  34 in total

1.  Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care.

Authors:  Sujha Subramanian; Justin Trogdon; Donatus U Ekwueme; James G Gardner; J Timothy Whitmire; Chandrika Rao
Journal:  Womens Health Issues       Date:  2010 Nov-Dec

Review 2.  Hysterectomy for the treatment of gynecologic malignancy.

Authors:  Floor J Backes; Jeffrey M Fowler
Journal:  Clin Obstet Gynecol       Date:  2014-03       Impact factor: 2.190

3.  Economies of scale in federally-funded state-organized public health programs: results from the National Breast and Cervical Cancer Early Detection Programs.

Authors:  Justin G Trogdon; Donatus U Ekwueme; Sujha Subramanian; Wesley Crouse
Journal:  Health Care Manag Sci       Date:  2013-12-11

4.  Cost of services provided by the National Breast and Cervical Cancer Early Detection Program.

Authors:  Donatus U Ekwueme; Sujha Subramanian; Justin G Trogdon; Jacqueline W Miller; Janet E Royalty; Chunyu Li; Gery P Guy; Wesley Crouse; Hope Thompson; James G Gardner
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

5.  Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.

Authors:  Marc Arbyn; Frank Buntinx; Marc Van Ranst; Evangelos Paraskevaidis; Pierre Martin-Hirsch; Joakim Dillner
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

6.  Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991-2007.

Authors:  Donatus U Ekwueme; Vladislav J Uzunangelov; Thomas J Hoerger; Jacqueline W Miller; Mona Saraiya; Vicki B Benard; Ingrid J Hall; Janet Royalty; Chunyu Li; Evan R Myers
Journal:  Am J Prev Med       Date:  2014-07-08       Impact factor: 5.043

7.  Social factors affecting treatment of cervical cancer: ethical issues and policy implications.

Authors:  Shannon N Westin; Dan Bustillos; Jacalyn B Gano; Margaret M Fields; Ann L Coker; Charlotte C Sun; Lois M Ramondetta
Journal:  Obstet Gynecol       Date:  2008-03       Impact factor: 7.661

8.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

9.  Cost-utility analysis of treatments for stage IB cervical cancer.

Authors:  Kanyarat Katanyoo; Naiyana Praditsitthikorn; Siriwan Tangjitgamol; Sumonmal Manusirivithaya; Busaba Supawattanabodee
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

10.  Viewing health expenditures, payment and coping mechanisms with an equity lens in Nigeria.

Authors:  Oforbuike Ewelukwa; Chima Onoka; Obinna Onwujekwe
Journal:  BMC Health Serv Res       Date:  2013-03-09       Impact factor: 2.655

View more
  1 in total

1.  Drivers of cervical cancer screening uptake in Ibadan, Nigeria.

Authors:  Oluwatosin E Ilevbare; A A Adegoke; C M Adelowo
Journal:  Heliyon       Date:  2020-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.